Showing 1 - 10 of 5,243
cartels. The number of cartel investigations has not risen appreciably. Moreover, the number of criminal Section 1 cases filed … annually fell. From 1995-99 to 2004-06 cartel cases filed fell by 49%. The number of corporations charged annually dropped … have grown. The total amount of cartel fines imposed is $4.2 billion. While an impressive amount, damages recouped by U …
Persistent link: https://www.econbiz.de/10014218279
Justice has great latitude in recommending corporate cartel fines to the federal courts, and its recommendations are nearly …-deterrence model is quite good. We find that U.S. corporate cartel fines are strongly directly related to economic injuries from …
Persistent link: https://www.econbiz.de/10013085647
The purpose of this paper is to examine whether the current cartel fine levels of the European Union and the United … results show that on average these cartel overcharges are significantly larger than the criminal fines of either the European …
Persistent link: https://www.econbiz.de/10014050311
Persistent link: https://www.econbiz.de/10000801510
Persistent link: https://www.econbiz.de/10013383575
Product differentiation is well established as being the key source of the cereal industry's high price-cost margins. However, there is little consensus as to whether pricing collusion is also a source of profitability, and indeed, whether price even serves as a strategic variable in this...
Persistent link: https://www.econbiz.de/10014215451
Persistent link: https://www.econbiz.de/10003863197
Persistent link: https://www.econbiz.de/10000900448
This paper provides an economic analysis of recent vertical and horizontal mergers in the U.S. industry for audiovisual media content, including the AT&T-Time Warner and the Disney-Fox mergers. Using a theory-driven approach, we examine economic effects of these types of mergers on market...
Persistent link: https://www.econbiz.de/10012011207
We study cartels that operated in the US generic drug industry, leveraging quarterly Medicaid data from 2011-2018 and a difference-in-differences approach comparing the evolution of prices of allegedly collusive drugs with a group of competitive control drugs. Our analysis highlights (i) the...
Persistent link: https://www.econbiz.de/10012670921